Zobrazeno 1 - 3
of 3
pro vyhledávání: '"tolerogenní dendritické buňky"'
Autor:
Grohová, Anna
Type 1 diabetes is characterized by chronic hyperglycaemia leading to life-threatening complication. The pathogenetic mechanism of T1D is the abnormal immune reaction destroying β-cell mass in pancreas. The current therapy is based on the administra
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2186::c515b9de88992d2211386a9acf13df82
http://www.nusl.cz/ntk/nusl-521784
http://www.nusl.cz/ntk/nusl-521784
Autor:
Kroulíková, Zuzana
Utilization of tolerogenic dendritic cells (tolDCs) as a cell-based therapy represents a promising strategy in treatment of autoimmune diseases including type 1 diabetes (T1D). Numerous protocols have been established to generate tolDCs ex vivo and t
Externí odkaz:
http://www.nusl.cz/ntk/nusl-406241
Autor:
Kroulíková, Zuzana
Utilization of tolerogenic dendritic cells (tolDCs) as a cell-based therapy represents a promising strategy in treatment of autoimmune diseases including type 1 diabetes (T1D). Numerous protocols have been established to generate tolDCs ex vivo and t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2186::f8cbd4fb8cec4fa71229d83dfc247b87
http://www.nusl.cz/ntk/nusl-406241
http://www.nusl.cz/ntk/nusl-406241